Annual Shareholders Equity
-$229.00 K
-$2.02 M-112.79%
31 December 2023
Summary:
Akari Therapeutics annual stockholders equity is currently -$229.00 thousand, with the most recent change of -$2.02 million (-112.79%) on 31 December 2023. During the last 3 years, it has fallen by -$9.61 million (-102.44%). AKTX annual shareholders equity is now -100.47% below its all-time high of $48.72 million, reached on 31 December 2015.AKTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$6.69 M
-$2.99 M-80.77%
01 September 2024
Summary:
Akari Therapeutics quarterly stockholders equity is currently -$6.69 million, with the most recent change of -$2.99 million (-80.77%) on 01 September 2024. AKTX quarterly shareholders equity is now -113.74% below its all-time high of $48.72 million, reached on 31 December 2015.AKTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -112.8% | - |
| 3 y3 years | -102.4% | -158.9% |
| 5 y5 years | -107.4% | -305.9% |
AKTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -102.4% | at low | -148.1% | at low |
| 5 y | 5 years | -102.4% | at low | -148.1% | at low |
| alltime | all time | -100.5% | +93.2% | -113.7% | at low |
Akari Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$6.69 M(+80.8%) |
| June 2024 | - | -$3.70 M(+4.2%) |
| Mar 2024 | - | -$3.55 M(+1451.5%) |
| Dec 2023 | -$229.00 K(-112.8%) | -$229.00 K(-108.2%) |
| June 2023 | - | $2.78 M(-66.6%) |
| Dec 2022 | $1.79 M(-67.8%) | - |
| June 2022 | - | $8.33 M(-40.2%) |
| Mar 2022 | - | $13.93 M(+150.8%) |
| Dec 2021 | $5.55 M(-40.8%) | $5.55 M(-51.1%) |
| Sept 2021 | - | $11.36 M(+615.5%) |
| June 2021 | - | $1.59 M(-59.7%) |
| Mar 2021 | - | $3.94 M(-58.0%) |
| Dec 2020 | $9.38 M(>+9900.0%) | $9.38 M(+93.2%) |
| Sept 2020 | - | $4.86 M(+45.5%) |
| June 2020 | - | $3.34 M(+83.9%) |
| Mar 2020 | - | $1.82 M(>+9900.0%) |
| Dec 2019 | $7600.00(-99.8%) | $7600.00(-99.8%) |
| Sept 2019 | - | $3.25 M(-336.8%) |
| June 2019 | - | -$1.37 M(-212.5%) |
| Mar 2019 | - | $1.22 M(-60.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $3.11 M(-81.9%) | $3.11 M(-50.6%) |
| Sept 2018 | - | $6.30 M(-26.9%) |
| June 2018 | - | $8.63 M(-47.2%) |
| Mar 2018 | - | $16.32 M(-4.8%) |
| Dec 2017 | $17.15 M(-49.7%) | $17.15 M(+31.5%) |
| Sept 2017 | - | $13.04 M(-42.9%) |
| June 2017 | - | $22.85 M(+2.0%) |
| Mar 2017 | - | $22.40 M(-34.3%) |
| Dec 2016 | $34.10 M(-30.0%) | $34.10 M(-16.9%) |
| Sept 2016 | - | $41.04 M(+1.1%) |
| June 2016 | - | $40.58 M(-12.5%) |
| Mar 2016 | - | $46.36 M(-4.8%) |
| Dec 2015 | $48.72 M(+2091.3%) | $48.72 M(+17.9%) |
| Sept 2015 | - | $41.33 M(+4147.8%) |
| June 2015 | - | $973.00 K(-62.5%) |
| Mar 2015 | - | $2.60 M(+16.7%) |
| Dec 2014 | $2.22 M(-61.8%) | $2.22 M |
| Dec 2013 | $5.81 M(-273.0%) | - |
| Dec 2012 | -$3.36 M(+35.2%) | - |
| Dec 2011 | -$2.48 M | - |
FAQ
- What is Akari Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Akari Therapeutics?
- What is Akari Therapeutics annual shareholders equity year-on-year change?
- What is Akari Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Akari Therapeutics?
What is Akari Therapeutics annual stockholders equity?
The current annual shareholders equity of AKTX is -$229.00 K
What is the all time high annual shareholders equity for Akari Therapeutics?
Akari Therapeutics all-time high annual stockholders equity is $48.72 M
What is Akari Therapeutics annual shareholders equity year-on-year change?
Over the past year, AKTX annual stockholders equity has changed by -$2.02 M (-112.79%)
What is Akari Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of AKTX is -$6.69 M
What is the all time high quarterly shareholders equity for Akari Therapeutics?
Akari Therapeutics all-time high quarterly stockholders equity is $48.72 M